To the Editor:
Dr. Dogan and Dr. Agilli raised several issues1 about our article2. The first issue was that the study population needed to be clearly defined, because comorbid diseases or medications might affect serum uric acid (SUA) levels. To address this issue, we performed medical chart review, which showed that the …
Address correspondence to Dr. J.H. Ju, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, #505, Banpo-Dong, Seocho-Gu, Seoul, South Korea. E-mail address: juji{at}catholic.ac.kr